Skip to main content

Table 4 Some in vivo studies in the field of BCBM

From: Breast cancer brain metastasis: from etiology to state-of-the-art modeling

Model

Cell line/animal

Outcome

Ref

BCBM model

MA11/athymic nude mice

Brain metastasis occurred 65 days after injection of MA1 I in the left ventricle of mice. Serum MUC1 levels produced by MA1 I cells are associated with brain metastasis. This model is useful for investigating the preferential mechanisms for metastases. This modeling did not cause bone, liver, kidney, spleen, and heart metastases

[60]

BCBM model

MDA-MB-231BR or MDA-231P / nude mice

MDA-231BR was metastases exclusively in the brain and did not cause bone metastases

MDA-231P metastasized to the brain, bone, adrenal glands, and ovaries

Provide a useful model for identifying new genes or molecules responsible for metastasis

[61]

BCBM model

MDA-MB-231 BR1, -BR2 and -BR3 / nude mice

Increased VEGF-A is a feature of brain metastatic cells

Mice injected with metastasis-selected cells had a shorter mean survival than mice injected with the main cell line

The VEGF-receptor tyrosine kinase inhibitor reduces brain metastases

[64]

BCBM model

JIMT-1-BR3/ NRC nu/nu mice

Temozolomide significantly prevented brain metastasis

[67]

BBB and BCBM model

CN34-BrM2/ nude mice

EGFR and COX2 ligands are involved in brain and pulmonary metastases

ST6GALNAC5 mediates brain metastasis exclusively, and its expression in BCCs increases their adhesion to brain endothelial cells and their passage through the BBB

[65]

BBB and BCBM model

SUM190-BR3/ Athymic NIH nu/nu mice

Targeting pericytes, Desmin, and α2 laminin are effective on BBB permeability and thus increase the effectiveness of chemotherapy

[80]

BCBM model

SKBrM3 + / nude mice

Cabozantinib and neratinib inhibited cell proliferation and migration; and inhibited tumor growth and brain metastasis

This model is a valuable tool for drug screening of brain metastases

[83]